Related Experiment Video
Updated: May 22, 2025

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
Cardiopulmonary exercise capacity markers and their link to symptom burden in patients at risk for heart failure with
Stefan Kwast1,2, Jana Hoffmann3, Christoph Pökel3
1Institute of Sports Medicine, University Leipzig, Leipzig, Germany. stefan.kwast@uni-leipzig.de.
Insights
This study found that heart failure (HF) symptom severity in Stage B patients with preserved ejection fraction weakly correlated with blood pressure and ventilatory inefficiency. However, correlations were moderate to strong with cardiac power output in men and ventilatory inefficiency in women.
Area of Science:
- Cardiology
- Exercise Physiology
- Heart Failure Research
Background:
- American Heart Association (AHA) guidelines assess heart failure (HF) using comorbidities, labs, and echocardiography.
- New York Heart Association (NYHA) classification focuses on functional capacity.
- Stage B HF with non-reduced ejection fraction (HFpEF) represents an early stage with potential for intervention.
Purpose of the Study:
- To investigate the correlation between HF-related symptoms and cardiac/muscular exercise capacity in Stage B HFpEF patients.
- To stratify analyses by NYHA class and sex to identify subgroup-specific relationships.
Main Methods:
- Sixty-two Stage B HFpEF patients underwent assessment including Kansas City Cardiomyopathy Questionnaire (KCCQ) for symptoms.
- Cardiopulmonary exercise testing (CPET) with cardiac output monitoring assessed exercise capacity (VO₂max, avDO₂, CPO, MAP, Ve/VO₂).
- Correlations were analyzed between KCCQ scores and exercise parameters, with subgroup analyses by NYHA class and sex.
Main Results:
- The cohort exhibited reduced KCCQ scores and VO₂max, with decreased arterio-venous oxygen difference (avDO₂).
- Overall, KCCQ scores showed moderate correlations with respiratory efficiency (Ve/VO₂) and mean arterial pressure (MAP).
- Sex-specific analyses revealed KCCQ correlated with cardiac power output (CPO) in men and Ve/VO₂ in women.
Conclusions:
- Stage B HFpEF patients demonstrate early alterations in exercise capacity and limitations.
- HF symptom severity is weakly associated with blood pressure and ventilatory inefficiency.
- Cardiac exercise capacity (CPO) in men and ventilatory inefficiency (Ve/VO₂) in women show stronger correlations with HF symptoms.
Abstract:
The American Heart Association (AHA) guidelines assess heart failure (HF) via comorbidities, laboratory markers, and echocardiography, while the New York Heart Association (NYHA) classification evaluates functional capacity. The primary objective of this study was to investigate the correlation between objectified HF-related symptoms and cardiac and muscular exercise capacity in Stage B HF patients with non-reduced ejection fraction. As secondary endpoints, we stratified this analysis for subgroups of NYHA classes to evaluate the primary endpoint for different levels of impairment and for sex to address for differences between men and women. Sixty-two Stage B HF patients with non-reduced EF were screened from an HF-risk cohort. Assessments included medical history, HF-related symptoms (Kansas City Cardiomyopathy Questionnaire, KCCQ), physical examination, laboratory tests, echocardiography, and cardiopulmonary exercise testing (CPET) with cardiac output monitoring. Correlations were analyzed between KCCQ score and exercise capacity markers: maximal oxygen uptake (VO2max), arterio-venous oxygen difference (avDO2), cardiac power output (CPO), mean arterial pressure (MAP), and respiratory efficiency (Ve/VO2). Subgroup analyses were performed by sex and NYHA class determined by VO2max or KCCQ functional scores. Our HF patient cohort showed reduced KCCQ scores (78.3) and VO₂max (22.9 ml/kg/min), and a progressed reduction in avDO₂. In the total cohort, KCCQ scores showed moderate correlations with Ve/VO₂ (r = -0.39) and MAP (r = 0.27). NYHA stratification by VO₂max revealed differences in avDO₂ and cardiac output but not KCCQ scores, while KCCQ-functional stratification only showed differences in Ve/VO₂. Sex-specific analysis showed KCCQ scores correlated with CPO in men (r = 0.65) and Ve/VO2 in women (r = -0.68). Our identified Stage B HFpEF cohort showed already alterations in total, cardiac and muscular exercise limitation. The HF symptom severity was weakly associated to the higher blood pressure and ventilatory inefficiency and, but moderately to strongly correlated CPO in men and Ve/VO2 in women in sex-specific analyses.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Heart Failure Drugs: β-Blockers
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...

